Drug Type Therapeutic vaccine |
Synonyms- |
Target |
Mechanism HSP stimulants(Heat-shock protein stimulants) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diffuse Intrinsic Pontine Glioma | Phase 1 | US | 10 Jan 2022 | |
Diffuse Intrinsic Pontine Glioma | Phase 1 | US | 10 Jan 2022 | |
Diffuse Intrinsic Pontine Glioma | Phase 1 | US | 10 Jan 2022 | |
Diffuse midline glioma, point mutation K27M in histone H3 | Phase 1 | US | 10 Jan 2022 | |
Diffuse midline glioma, point mutation K27M in histone H3 | Phase 1 | US | 10 Jan 2022 | |
Diffuse midline glioma, point mutation K27M in histone H3 | Phase 1 | US | 10 Jan 2022 | |
Dimethylglycine Dehydrogenase Deficiency | Phase 1 | US | 10 Jan 2022 | |
Dimethylglycine Dehydrogenase Deficiency | Phase 1 | US | 10 Jan 2022 | |
Dimethylglycine Dehydrogenase Deficiency | Phase 1 | US | 10 Jan 2022 |